These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2016931)

  • 41. [Antihypertensive treatment. Benefits and costs].
    Jensen HA; Svendsen TL
    Ugeskr Laeger; 1993 Jan; 155(2):118-20. PubMed ID: 8421861
    [No Abstract]   [Full Text] [Related]  

  • 42. [Care in hypertension: guidelines and sources of error].
    Simon G
    Orv Hetil; 2005 May; 146(18):849-52. PubMed ID: 15926631
    [No Abstract]   [Full Text] [Related]  

  • 43. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
    Rorive G; Delporte JP
    Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark].
    Keiding H; Hildebrandt P; Burke T; Carides GW
    Ugeskr Laeger; 2006 Oct; 168(42):3623-6. PubMed ID: 17069726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effective therapy for hypertension.
    Barrie W
    West J Med; 1996 Apr; 164(4):303-9. PubMed ID: 8732729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The Swedish Society of Hypertension: cooperation with industry is desirable and necessary--with integrity preserved].
    Nilsson P; Hedner T; Himmelmann A; Kahan T; Manhem K; Norrvinsdotter-Borg I; Nyström F; Svensson P; Wallén T
    Lakartidningen; 2003 May; 100(21):1919-20. PubMed ID: 12815881
    [No Abstract]   [Full Text] [Related]  

  • 47. Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.
    Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B;
    Heart; 2008 Feb; 94(2):e4. PubMed ID: 17916665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical importance of direct hospital costs in patients with arterial hypertension in a university hospital, Rio de Janeiro, Brazil].
    de Souza e Silva NA; Aguiar GR; Nogueira Ada R; Duarte MM; Alves RH
    Rev Saude Publica; 1986 Aug; 20(4):293-302. PubMed ID: 3576101
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of poorly controlled hypertension on healthcare resource utilization and cost.
    Paramore LC; Halpern MT; Lapuerta P; Hurley JS; Frost FJ; Fairchild DG; Bates D
    Am J Manag Care; 2001 Apr; 7(4):389-98. PubMed ID: 11310193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertension treatment and control in Sub-saharan Africa. Figure of $1800 per life saved seems optimistic.
    Burdon J
    BMJ; 1998 Jul; 317(7150):76; author reply 77. PubMed ID: 9651283
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current views on hypertension].
    Lakartidningen; 1975 Oct; 72(40):3821-7. PubMed ID: 1177611
    [No Abstract]   [Full Text] [Related]  

  • 52. Cost effectiveness in the treatment of hypertension.
    Burns R
    Clin Geriatr Med; 1989 Nov; 5(4):829-40. PubMed ID: 2514038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost as a factor in the treatment of hypertension.
    Dart RA
    Contemp Intern Med; 1995 Feb; 7(2):10-4. PubMed ID: 10150334
    [No Abstract]   [Full Text] [Related]  

  • 54. [Rational prescribing in patients with arterial hypertension].
    Torres Pacho JA; Mora Guío FJ; Charques Velasco E; Alonso Martínez MM
    Gac Sanit; 2002; 16(2):196-7; author reply 197. PubMed ID: 11958758
    [No Abstract]   [Full Text] [Related]  

  • 55. Cost of care of the hypertensive in the primary preventive trial, Gothenburg.
    Wilhelmsen L; Berglund G; Wedel H
    Acta Med Scand Suppl; 1979; 626():44-6. PubMed ID: 285593
    [No Abstract]   [Full Text] [Related]  

  • 56. [Social causes of hypertension].
    Grönqvist J
    Lakartidningen; 1977 Nov; 74(45):3968-70. PubMed ID: 926936
    [No Abstract]   [Full Text] [Related]  

  • 57. Standardized investigation programme on patients with hypertension--a cost analysis.
    Forsberg SA
    Acta Med Scand Suppl; 1979; 626():51-3. PubMed ID: 285595
    [No Abstract]   [Full Text] [Related]  

  • 58. [Editorial: Medicated society?].
    Ravnskov U; Gunnarsson C
    Lakartidningen; 1976 Mar; 73(14):1298. PubMed ID: 1263646
    [No Abstract]   [Full Text] [Related]  

  • 59. [The lipid hypothesis--who will pay the bill?].
    Meland E
    Tidsskr Nor Laegeforen; 1991 Jan; 111(2):235-6. PubMed ID: 1998189
    [No Abstract]   [Full Text] [Related]  

  • 60. Expenses concerning evaluation and treatment of hypertension.
    Kringsholm B; Hilden T
    Acta Med Scand Suppl; 1979; 626():47-50. PubMed ID: 285594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.